The absence of beneficial effects by TREM2 elevation in microglia may attribute to the reduced expression of Aβ-binding receptors in the aged [27], highlighting the importance of early therapeutic interventions targeting TREM2 for AD. Here, TREM2 is linked to Alzheimer disease.